Peng Wang | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Peng Wang | Neuroscience | Best Researcher Award

Ningxia Medical University | China

Dr. Peng Wang is a distinguished cell biologist specializing in neurobiology, remyelination, and the molecular mechanisms underlying demyelinating diseases. His research focuses on the roles of microglia, macrophages, and the extracellular matrix in regulating remyelination and neuroinflammation, particularly in models of multiple sclerosis and epilepsy. He has made significant contributions to understanding how fibronectin aggregates, MMP7 activity, and signaling pathways affect myelin repair. Dr. Peng Wang has an extensive publication record in high-impact journals such as GLIA, Journal of Neuroscience Research, and International Journal of Biological Macromolecules, with a total of 15 publications indexed in Scopus, accumulating over 91 citations and an h-index of 6. His work integrates advanced techniques including immunofluorescence, confocal and live-cell imaging, molecular biology assays, and animal models to elucidate neurobiological processes. He has led and contributed to multiple nationally funded research projects, including several from the National Natural Science Foundation of China, focusing on myelin biology, remyelination, and neurodegeneration. Dr. Peng Wang has supervised master’s and bachelor’s students, contributed to innovation in neurobiology research, and received numerous awards and fellowships recognizing his scientific excellence, including CSC Fellowship and national-level scholarships. His research continues to impact the understanding of demyelinating diseases and therapeutic strategies for neurological disorders.

Profile: Scopus

Featured Publications

  • Wang, P., Ma, K., Yang, L., Zhang, G., Ye, M., Wang, S., Wei, S., Chen, Z., Gu, J., Zhang, L., Niu, J., & Tao, S.* (2021). Predicting signaling pathways regulating demyelination in a rat model of lithium-pilocarpine-induced acute epilepsy: A proteomics study. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2021.10.209

  • Zhang, F., Shi, J., Duan, Y., Cheng, J., Li, H., Xuan, T., Lv, Y., Wang, P#, & Li, H. (2021). Clinical features and related factors of freezing of gait in patients with Parkinson’s disease. Brain and Behavior. https://doi.org/10.1002/brb3.2359

  • de Jong, J. M.#, Wang, P.#, Oomkens, M.#, & Baron, W.* (2020). Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure). Journal of Neuroscience Research, 00(00), 1–28.

  • Huo, J., Ren, S., Gao, P., Wan, D., Rong, S., Li, X., Liu, S., Xu, S., Sun, K., Guo, B., Wang, P., Yu, B., Wu, J., Wang, F., & Sun, T. (2020). ALG13 participates in epileptogenesis via regulation of GABAA receptors in mouse models. Cell Death Discovery, 6, 87. https://doi.org/10.1038/s41420-020-00319-6

  • Wan, D., Yang, L., Ren, J., Huang, H., Zhang, C., Chen, L., Su, X., Huang, Q., Niu, J., Sun, T., & Wang, P. (2022). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the hippocampus of lithium-pilocarpine-induced acute epileptic rats. Molecular Biology Reports, 49(7), 5805–5810. https://doi.org/10.1007/s11033-022-07277-5

Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Prof. Zhiliang Xu | Medicine and Health Sciences | Best Researcher Award

Wannan Medical College | China

Prof. Zhiliang Xu, affiliated with Wannan Medical College, Wuhu, China, is a distinguished molecular biologist and epigenetics researcher whose work focuses on histone ubiquitination, chromatin remodeling, and their implications in neurological disorders, cancer, gametogenesis, and cellular reprogramming. He earned his Ph.D. from the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences in 2017. According to Scopus, Prof. Zhiliang Xu has authored 11 publications, which have been cited 34 times, and he holds an h-index of 4, demonstrating the impact of his research in the scientific community. His seminal studies elucidated the role of H2B ubiquitination in chromatin relaxation during meiosis and cellular reprogramming, published in journals such as Nucleic Acids Research (2016), Cell Proliferation (2021), and Reproduction (2017). His recent work on neuronal repair, gut-liver axis regulation in diabetes, and genomic approaches to thalassemia has been featured in FASEB Journal (2025), Annals of Hematology (2025), and Neuroscience Letters (2025). Prof. Zhiliang Xu leads multiple high-impact national and provincial research projects, serves as a peer reviewer for journals including Scientific Reports and Neurochemical Research, and evaluates theses for graduate and doctoral candidates. Recognized with the 2021 National Maternal and Child Health Science and Technology Award (First Prize), the 2022 Guangzhou High-level Talent Award, and the 2024 Outstanding Young Talent honor in Anhui Province, Prof. Zhiliang Xu continues to advance fundamental understanding of chromatin biology and epigenetic regulation, exemplifying excellence, mentorship, and translational scientific impact, making him an outstanding candidate for the Best Researcher Award.

Profile: Scopus | ORCID

Featured Publications

1. Shi, L., Yan, X., Xia, Y., Zhao, Y., Zhu, X., Li, Q., & Xu, Z. (2025). Beyond transfusions and transplants: Genomic innovations rewriting the narrative of thalassemia. Annals of Hematology.

2. Zhang, Y., Wang, J., Huang, S., Liu, M., Zhao, Y., Xu, Z., & Zhu, X. (2025). Electroacupuncture preconditioning alleviates cortical neuronal injury in cerebral ischemia-reperfusion by rebalancing HES1 and NF-κB expression. Neuroreport.

3. Yan, X., Shi, L., Zhu, X., Zhao, J., Zhao, Y., Luo, J., Li, Q., & Xu, Z. (2025). From microbial homeostasis to systemic pathogenesis: A narrative review on gut flora’s role in neuropsychiatric, metabolic, and cancer disorders. Journal of Inflammation Research.

4. Huang, S., Lu, Y., Fang, W., Huang, Y., Li, Q., & Xu, Z. (2025). Neurodegenerative diseases and neuroinflammation-induced apoptosis. Open Life Sciences.

5. Li, Q., Zhang, L., Sun, Y., Du, Z., Xu, S., Wang, X., Wei, S., Tao, Y., Li, B., Jiang, J., Di, G., Huang, Y., & Xu, Z. (2025). p53 modulates the gut-liver axis via PI3K/AKT/Wnt signaling pathways in type 2 diabetes. FASEB Journal.

6. Li, Q., Yan, X., Zhao, Y., Xu, Z., & Zhu, X. (2025). Paeonol mitigates chronic stress-induced amygdalar neuronal damage through glycogen synthase kinase-3β/calcineurin axis regulation of synaptic plasticity. Neuroreport.

7. Zhu, X., Zhang, Y., Yan, X., Zhao, Y., Shi, L., Sun, Z., Meng, K., Zong, Y., Li, Q., & Xu, Z. (2025). Paeonol facilitates the repair of neuronal damage in the mPFC caused by chronic stress via the Rho GTPases-cofilin1 signaling pathway. Neuroscience Letters, 138329.

Xiuqin Jia | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Xiuqin Jia | Neuroscience | Best Researcher Award

Beijing Chaoyang Hospital | China

Dr. Xiuqin Jia, Ph.D., Associate Professor in the Department of Radiology at Beijing Chaoyang Hospital, Capital Medical University, is a distinguished researcher whose work has significantly advanced the fields of neuroimaging and cognitive neuroscience. Her research addresses the neural correlates of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, and mild cognitive impairment, as well as cerebrovascular disorders including CADASIL and cerebral small vessel disease. Through computational modeling and multimodal neuroimaging approaches, she has provided innovative insights into disease mechanisms, progression, and early diagnostic markers, with direct implications for clinical practice and therapeutic intervention. According to Scopus, Dr. Xiuqin Jia has authored 75 publications, which have collectively received 1,716 citations across 1,492 documents, establishing a robust h-index of 23 that reflects her sustained impact and scholarly influence. She has successfully secured major funding as Principal Investigator for projects under the National Natural Science Foundation of China, the Beijing Municipal Natural Science Foundation, and other national programs, underscoring her leadership in cutting-edge research. In addition to her academic contributions, Dr. Xiuqin Jia serves as a Review Editor for Frontiers in Aging Neuroscience and holds important positions in multiple professional societies, promoting interdisciplinary collaboration between radiology, brain science, and artificial intelligence. Her achievements have been recognized through prestigious honors, including the Beijing Outstanding Doctoral Graduate Award, the Capital Medical University Scientific and Technological Progress Award, and the Chinese Medical Science and Technology Youth Award. With her remarkable record of innovation, leadership, and international recognition, Dr. Jia is an outstanding candidate for the Best Researcher Award.

Profile: Scopus | Google Scholar | ORCID

Featured Publications

Huang, Z., Liang, P., Jia, X., Zhan, S., Li, N., Ding, Y., Lu, J., Wang, Y., & Li, K. (2012). Abnormal amygdala connectivity in patients with primary insomnia: Evidence from resting state fMRI. European Journal of Radiology, 81(6), 1288–1295.

Liang, P., Wang, Z., Yang, Y., Jia, X., & Li, K. (2011). Functional disconnection and compensation in mild cognitive impairment: Evidence from DLPFC connectivity using resting-state fMRI. PLoS ONE, 6(7), e22153.

Wang, Z., Jia, X., Liang, P., Qi, Z., Yang, Y., Zhou, W., & Li, K. (2012). Changes in thalamus connectivity in mild cognitive impairment: Evidence from resting state fMRI. European Journal of Radiology, 81(2), 277–285.

Duan, Y., Liu, Y., Liang, P., Jia, X., Yu, C., Qin, W., Sun, H., Liao, Z., Ye, J., & Li, K. (2012). Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: A voxel-based morphometry study. European Journal of Radiology, 81(2), e110–e114.

Wang, Z., Liang, P., Jia, X., Jin, G., Song, H., Han, Y., Lu, J., & Li, K. (2012). The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: A combined structure and resting-state fMRI study. PLoS ONE, 7(5), e36838.

Wang, Z., Liang, P., Jia, X., Qi, Z., Yu, L., Yang, Y., Zhou, W., Lu, J., & Li, K. (2011). Baseline and longitudinal patterns of hippocampal connectivity in mild cognitive impairment: Evidence from resting state fMRI. Journal of the Neurological Sciences, 309(1–2), 79–85.

Jia, X., Liang, P., Li, Y., Shi, L., Wang, D., & Li, K. (2015). Longitudinal study of gray matter changes in Parkinson disease. American Journal of Neuroradiology, 36(12), 2219–2226.

Liu, Y., Liang, P., Duan, Y., Jia, X., Wang, F., Yu, C., Qin, W., Dong, H., Ye, J., & Li, K. (2011). Abnormal baseline brain activity in patients with neuromyelitis optica: A resting-state fMRI study. European Journal of Radiology, 80(2), 407–411.

Chengqun Wei | Neuroscience | Best Researcher Award

Published on by Forensic Scientist

Mr. Chengqun Wei | Neuroscience | Best Researcher Award

Associate Chief Physician | Huaian Hospital of Huaian city (Huaian Cancer Hospital) | China

Dr. Chengqun Wei is the Director of the Neurology Department and an Associate Senior Physician at Huaian Hospital of Huaian City. With a medical doctorate and a specialization in neurology, he has accumulated extensive expertise in geriatric neurology. Since beginning his medical career in 2012, Dr. Wei has dedicated over seven years to the treatment of acute cerebrovascular diseases, neurological infections, and demyelinating disorders. His vast clinical experience also includes managing elderly patients with comorbidities such as hypertension, diabetes, and cardiovascular diseases.

Profile👤

Scopus

Strengths for the Awards✨

✅ Extensive Medical Expertise: With a Ph.D. in Neurology and over a decade of clinical experience, Dr. Wei has demonstrated profound knowledge in geriatric neurology, cerebrovascular diseases, and neurological infections. His ability to manage complex neurological conditions in elderly patients is highly commendable.

✅ Research Contributions: Dr. Wei has authored 7 SCI-indexed publications, indicating a strong research output. Additionally, his involvement in multiple provincial-level research projects as a principal investigator or key participant highlights his active role in advancing medical knowledge.

✅ Technical Proficiency: His expertise in network pharmacology, bioinformatics analysis, and web data mining showcases his ability to integrate computational tools with medical research, a valuable asset in modern biomedical sciences.

✅ Leadership & Experience: Holding senior positions such as Associate Chief Physician and Director of Neurology, Dr. Wei has both clinical and research leadership experience, reinforcing his credentials as a top researcher.

🎓 Education

  • 🎓 2004.09-2009.06 – Xinxiang Medical University – Clinical Medicine (BD)
  • 🎓 2009.09-2012.06 – Harbin Medical University – Neurology (MD)
  • 🎓 2020.09-2023.06 – Harbin Medical University – Neurology (PhD)

💼 Experience

  • 2012.07-2015.05 – Resident Physician, Heilongjiang Provincial Hospital
  • 2015.05-2021.08 – Attending Physician, Heilongjiang Provincial Hospital
  • 2021.09-2024.03 – Associate Chief Physician, Heilongjiang Provincial Hospital
  • 2024.03-Present – Associate Chief Physician, Huaian Hospital of Huaian City

🔬 Research Interests On Neuroscience

Dr. Wei’s research focuses on network pharmacology, bioinformatics analysis, and web data mining for scientific research. His work contributes to advancements in understanding neurological diseases, particularly in geriatric populations. He is proficient in analyzing large-scale medical data and has authored multiple research papers in high-impact journals.

🏆 Awards

  • 🌟 Principal investigator or key participant in multiple provincial-level research projects.
  • 🌟 Recognized for excellence in neurology research and contributions to geriatric neurological care.

📚 Publications

  • Title: Single cell analysis reveals the roles and regulatory mechanisms of type-I interferons in Parkinson’s disease
  • Authors: Quan P., Li X., Si Y., Yang F., Yao L., and others
  • Publication Year: 2024
  • Journal: Cell Communication and Signaling
  • Citations: 4

🔚 Conclusion

Dr. Chengqun Wei is a highly skilled neurologist with a strong academic background and clinical expertise in geriatric neurology. His contributions to research, particularly in bioinformatics and pharmacology, have positioned him as a key figure in neurological studies. His dedication to patient care and medical advancements continues to make a significant impact in the field of neurology.